October 16, 2024
The U.S. Securities and Exchange Commission is ready to make a deal with a former cannabidiol products executive accused of taking $13 million from a hospital after falsely promising to deliver urgently needed masks during the height of the pandemic.
October 01, 2024
The U.S. Securities and Exchange Commission sufficiently backed its claims that a former cannabidiol products executive misled investors, including by making false statements in press releases, a Connecticut federal judge has ruled.
September 25, 2023
The U.S. Securities and Exchange Commission filed a new complaint against the former chief executive officer of a pain management and cannabidiol products company, alleging that he tricked a hospital into paying $13 million for millions of sorely needed N-95 masks during the COVID-19 pandemic despite knowing he could not deliver.